 | Ensysce Biosciences, Inc. | |||
| NCM : ENSC || Location: United States | ||||
$0.55-0.01 (-2.15%) |
0.06 M | 0.54 - 0.57 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.004 M |
| March 28, 2024 | 0.017 M |
| March 15, 2024 | 0.057 M |
| Feb. 29, 2024 | 0.086 M |
| Feb. 15, 2024 | 0.061 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.89 | -1.37 | -54.38% |
| 09/30/2023 | -1.08 | -0.87 | 19.28% |
| 06/30/2023 | -2.78 | -0.98 | 64.76% |
| 03/31/2023 | -5.18 | -2.08 | 59.83% |
| 12/31/2022 | -29.46 | -18.24 | 38.08% |
ENSC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 7.585M | Shares Float | 7.149M |
| Short Float | 0.004M | Market Cap | 4.17M |
| Institution ownership | 2.32% | Insider ownership | 5.552% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.69 | Forward EPS | -2.33 |